title: Ifosfamide-induced encephalopathy due to a novel formulation of ifosfamide.
authors.affiliation: Department of Pediatric Hematology and Oncology, Rouen University Hospital, Rouen, France.
authors.forename: Bruno
authors.initials: B
authors.lastname: Filhon
authors.affiliation: Department of Pediatric Hematology and Oncology, Rouen University Hospital, Rouen, France.
authors.forename: Boris
authors.initials: B
authors.lastname: Lacarra
authors.affiliation: Department of Pharmacy, Rouen University Hospital, Rouen, France.
authors.forename: Charles
authors.initials: C
authors.lastname: Hervouet
authors.affiliation: Department of Pediatric Hematology and Oncology, Rouen University Hospital, Rouen, France.
authors.forename: Marie
authors.initials: M
authors.lastname: Jaffray
authors.affiliation: Department of Pediatric Hematology and Oncology, Rouen University Hospital, Rouen, France.|Laboratory MERCI EA 3829, University of Rouen, France.
authors.forename: Pascale
authors.initials: P
authors.lastname: Schneider
authors.affiliation: Department of Pediatric Hematology and Oncology, Rouen University Hospital, Rouen, France.|Laboratory MERCI EA 3829, University of Rouen, France.
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Vannier
mesh_terms: D000293:Adolescent; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage* / Q000009:adverse effects*; D001927:Brain Diseases / Q000139:chemically induced*; D002626:Chemistry, Pharmaceutical; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage* / Q000009:adverse effects*; D007223:Infant; D008297:Male; D011208:Powders; D055815:Young Adult
chemical_list: D018906:Antineoplastic Agents, Alkylating; D011208:Powders; D007069:Ifosfamide